Delivery Order SPE2DB20D2104-SPE2DB23FV24Z
Award Date 9/8/23
Potential Completion Date 9/11/23
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract award, valued at $1,214.38, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $10,623.96, is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,853.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,019.23 to supply Oseltamivir Phosphate 75 mg capsules to support military treatment programs and facilities. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.66 firm fixed-price delivery order is for the supply of 4,563,755,824 units of the drug Oseltamivir Phosphate 45 mg capsules. The contract has an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,703.80 and a performance period through March 19, 2024. It is not associated with any set-aside...
- This contract award is for the delivery of 4,563,518,552 capsules of the pharmaceutical drug Oseltamivir Phosphate 75 mg to the Defense Logistics Agency (DLA). The $7,193.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2024. The contract has a period of performance through February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- The federal contract award, with ID SPE2DB20D7059|SPE2DB25FPXY7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.86 firm fixed-price delivery order contract is for the supply of 4566918317 units of Oseltamivir Phosphate 30 mg capsules. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support...
- The Defense Logistics Agency awarded a $1,243.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on January 14, 2026, with completion targeted for January 15, 2026. The award, issued without set-aside restrictions, represents a competitively awarded task order for pharmaceutical supply to support federal medical needs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is headquartered in...
- This federal contract award, with ID SPE2DX15D1104|SPE2DX23F3WD2, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $10,555.92 firm-fixed-price delivery order is for the supply of 4,561,934,943 units of Oseltamivir Phosphate 75 mg capsules. This award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal...